It was previously reported that the oncogene MN1 was hypomethylated and overexpressed in CBFB-MYH11 mutant AML patients, partially due to the decreased expression of DNMT3B (Larmonie et al., 2018). Here, DNMT3B is linked to acute myeloid leukemia.